Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProHydrolase is a proprietary, clinically studied blend of protease enzymes developed to enhance the digestion of dietary proteins and optimize protein hydrolysis. Its mechanism of action centers on breaking down protein supplements—such as whey, casein, soy, egg, pea, and hemp—into smaller absorbable peptides and amino acids, which increases amino acid levels in the blood and supports muscle recovery and growth. Clinical studies demonstrate that when added to protein supplements, ProHydrolase can significantly elevate plasma levels of leucine, BCAAs, and total essential amino acids, thus improving their bioavailability. It also reduces the likelihood of digestive discomfort associated with undigested protein[1][2][4][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ProHydrolase.